Supreme Court Sides With Hospitals on Medicare Reimbursement (1)

June 15, 2022, 9:20 AM

The U.S. Supreme Court said the federal government improperly cut more than $1 billion a year in Medicare reimbursements to hospitals in a ruling that limits regulators’ power to control what the program pays for some drugs.

The justices on Wednesday unanimously sided with the American Hospital Association in a clash over drug reimbursement rates for facilities that serve low-income communities.

Writing for the court, Justice Brett Kavanaugh said the Department of Health and Human Services improperly calculated reimbursement rates using a methodology Congress authorized only in limited circumstances.

The federal government said the rate cuts, which started in 2018, were designed to more closely track the cost to hospitals of acquiring the drugs.

But Kavanaugh said that under the 2003 law that expanded Medicare to cover prescription drugs, HHS generally must tie the reimbursement rate to each drug’s average sales price. The law lets HHS use a drug’s acquisition cost only if regulators have conducted a survey to determine what hospitals are paying, Kavanaugh said.

The government argued that HHS could rely on a separate provision that says regulators can make “adjustments” to rates.

The justices declined the Biden administration’s call to apply a legal doctrine known as Chevron deference. Under that approach, which some conservative justices have questioned, courts defer to federal agencies on the meaning of ambiguous statutes.

The case is American Hospital Association v. Becerra, 20-1114.

Supreme Court Sides With Hospitals on Medicare Reimbursement (1) (bloomberglaw.com)

Atlanta system 1st in US to face CMS fines for price transparency violations

Andrew Cass and Marissa Plescia – Thursday, June 9th, 2022

Atlanta-based Northside Hospital is the first health system in the nation to be fined by CMS for violating federal price transparency laws, CMS told Becker’s. 

Northside was fined more than $1 million, according to CMS. Northside Hospital Atlanta, the health system’s flagship facility, was fined $883,180, according to CMS. Northside Hospital Cherokee in Canton, Ga., was fined $214,320.

CMS said Northside Hospital Atlanta didn’t have a searchable list for consumers posted in a prominent manner that clearly identified the location of the hospital concerned, according to the report. CMS said “no consumer-friendly list of standard charges was found,” for Northside Hospital Cherokee. 

Northside told the Atlanta Journal-Constitution last year that the information required by the federal government would not actually be useful to consumers because it lacked context, according to the report. Prices paid by patients can vary depending on factors like insurance contract negotiations. 

CMS also said Northside didn’t include all required services in a machine-readable file, and services weren’t included in a single file, according to the report. 

As of early June, CMS has issued about 352 warning notices to hospitals that were found out of compliance with price transparency rules, which went into effect Jan. 1, 2021. CMS has also sent 157 requests for a corrective action plan to hospitals that received a warning and had not made any corrections. There have been 171 hospitals who have had their cases closed after addressing issues.

CMS told Becker’s the Northside hospitals received a notice and a corrective action plan request, but neither hospital submitted a plan, and both remained noncompliant.

“CMS expects hospitals to comply with the hospital price transparency regulations that require providing clear, accessible pricing information online about the items and services they provide,” Meena Seshamani, MD, PhD, CMS deputy administrator and director of the Center for Medicare, told Becker’s. “This enforcement action affirms the Biden-Harris administration’s commitment to making healthcare pricing information accessible to people across the country, and we are committed to ensuring that consumers have the information they need to make fully informed decisions regarding their healthcare.”

Atlanta system 1st in US to face CMS fines for price transparency violations (beckershospitalreview.com)

Deferred care, inflation fuel mounting cost pressure for Americans’ healthcare

Becker’s Hospital Review by Molly Gamble

Americans aged 50 and older are feeling the pressure of healthcare costs, with 4 in 10 concerned about their ability to pay for care and others forgoing treatment altogether, skipping prescriptions or cutting back on daily living expenses to afford healthcare.

The findings come from a survey of 6,663 U.S. adults conducted by West Health and Gallup in September and October 2021. 

Increased use of general healthcare —driven by care deferred in 2020 that was provided in 2021 — may be driving up costs, leaving Americans finding the cost burden of healthcare more extreme than what they remembered pre-pandemic. At the same time, a fragile economy and rising consumer costs are intensifying the squeeze. Healthcare costs have grown at a rate double that of Americans’ incomes for decades, but inflation reaching a 30-year high and intensifying global supply chain shortages have households across every income bracket feeling cost pressures in new ways.

“Nearly two years into the COVID-19 pandemic, we are beginning to see the long-term impact on healthcare costs emerge,” the survey states. “Significantly worsening trends uncovered in recent months underscore the urgency of the U.S. healthcare cost crisis today and the dire projections for the coming years.”

“The growing burden of cost is coupled with worsening and widespread pessimism about any kind of solution or reprieve,” survey authors noted. “The power for change, U.S. adults report, lies in the hands of the U.S. Congress and with American businesses. There is also a shared expectation that costs will continue to climb in the year ahead, leaving Americans resigned to the idea that the burgeoning cost crisis — which is estimated to have claimed the lives of more than 12 million Americans this year alone — will persist.” 

Here are six key takeaways from the 31-page survey: 

1. The financial burdens of healthcare are especially palpable for Americans aged 50-64, who are old enough to experience health problems but too young to qualify for Medicare. Of this age bracket, 26 percent of survey respondents said they or a member of their household recently did not seek treatment because of its cost. Twelve percent of adults 65 and older said the same. 

2. Eighteen percent of Americans aged 50-64 and 11 percent of Americans aged 65 and older said they or a family member skipped prescribed medication in the last year to save money. 

3. A sizable minority of Americans aged 65 and older make daily sacrifices to afford healthcare. About 1 in 4adults in this age bracket cut back on at least one basic need to pay for healthcare, including reduced spending on food (9 percent), reduced spending on over-the-counter drugs (13 percent), cutbacks on utilities (6 percent) and reduced spending on clothing (19 percent). 

4. The financial stress and sacrifices to shore up money for healthcare was even more prevalent for Americans aged 50 to 64, with 3 in 10 forgoing at least one basic need. This includes reduced spending on food (14 percent), reduced spending on over-the-counter drugs (15 percent), and reduced spending on clothing (26 percent). Similar to the adults aged 65 and older, 8 percent of those aged 50-64 reduced spending on utilities to pay for healthcare.

5. Black Americans aged 50-64 are more likely than white Americans to report forgoing at least one basic need asked about in the survey (38 percent to 29 percent, respectively).

6. The growing burden of cost is coupled with worsening and widespread pessimism about healthcare. Nearly half of Americans (48 percent) report that COVID-19 made their view of the U.S. healthcare system worse. This percentage grows larger the younger the age group, with 58 percent of those under the age of 30 saying they feel this way compared to 38 percent of adults 65 and older.

Deferred care, inflation fuel mounting cost pressure for Americans’ healthcare (beckershospitalreview.com)

Thermo Fisher Scientific and LabShares Partner to Support Emerging Boston Biotechs

WILMINGTON, N.C. (May 19, 2022) – To support the Greater Boston biotech ecosystem, Thermo Fisher Scientific is joining forces with biotech incubator LabShares Newton to provide instruments, lab equipment and consumables to help early-stage life sciences companies accelerate their drug discovery efforts.

LabShares provides fully furnished lab space, services and equipment to more than 25 biotech companies, alleviating logistics constraints to help them bring novel therapeutics to market. Thermo Fisher will outfit the shared lab space with equipment including ultra-low temperature freezers, cell culture incubators, microscopes and PCR instruments.
 

“Thermo Fisher Scientific is incredibly excited to partner with LabShares in support of the emerging life science and biotech companies in Newton,” said Angela N. Hokanson, vice president, corporate accounts, Thermo Fisher Scientific. “In line with our mission to enable our customers to make the world healthier, cleaner and safer, we look forward to collaborating with LabShares and their members to innovate, validate and commercialize the next generation of life-saving therapies.”
 

“With little lab space available in historic biotech hubs such as Cambridge, emerging companies are looking to the suburbs for more accessible and affordable lab space,” said Jeff Behrens, CEO and founder, LabShares. “Working with partners such as Thermo Fisher allows LabShares to provide a caliber of equipment that smaller companies may not otherwise have access to, empowering promising biotech startups to hit the ground running.”
 

While investment in the biotech industry continues to climb, the high cost of bringing drugs through research and development to the market is limiting many early-stage companies from flourishing. By offering alternative lab space and more tailored support and resources, LabShares and its partners are helping emerging biotech companies clear hurdles that previously hindered growth for smaller companies trying to break through the market.


About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Hospitals await HHS move on public health emergency today

Molly Gamble (Twitter) – Monday, May 16th, 2022

HHS pledged to provide 60 days’ notice if it opts to end the COVID-19 public health emergency, leaving healthcare providers awaiting word on Monday.

The American Hospital Association and 15 other national healthcare organizations are calling on HHS to maintain the PHE. In a May 10 letter to HHS Secretary Xavier Becerra, the organizations cited the continued risk from COVID-19 variants, as well as rising case rates in the U.S. The organizations requested that HHS maintain the public health emergency “until it is clear that the global pandemic has receded, and the capabilities authorized by the PHE are no longer necessary.”

Congressional Republicans have been urging President Joe Biden and HHS Secretary Xavier Becerra to end the declaration for months, penning a letter to them in February to end the declaration of COVID-19 as a public health emergency. 

The Trump administration declared the coronavirus a public health emergency in late January 2020. HHS has continued to extend the declaration since; it is renewed for 90-day increments. The declaration was last extended April 13 with a deadline of July 15. HHS has said it will give states 60 days’ notice before terminating the declaration or allowing it to expire. 

For an overview of the flexibilities tied to the PHE and what occurs when the declaration ends, check out a comprehensive brief from Kaiser Family Foundation here

Rising Equipment Costs & What Healthcare Providers Can Do About It

In collaboration with Med One

The complexities of equipment acquisition in the healthcare space are growing by the day. Broad contributing factors include geopolitical unrest, labor shortages, supply chain issues, inflation, and rising interest rates. Any one of these factors is challenging enough, but the combination of them all means a bumpy economic road ahead. Thus, wise business leaders and purchasing professionals will seek to be well informed and ready to utilize tools and strategies that can help navigate through these challenging times in a balanced and effective manner.

Why Equipment Costs Are Increasing

Inflation will likely be a reality for the long-term. What does that mean for supply chain managers? Over the next few years, the cost of just about everything may continue to rise at a much more steady pace than we’ve been used to for decades. The clear and simple reality that inflation creates for any business is this: Purchasing equipment and supplies will cost less today than it will next year, next quarter, or even next month. As the price of everything rises, the purchasing power of tomorrow’s dollars will continually diminish.

As of March 16th, the Federal Reserve officially began the long-speculated process of raising interest rates. Many economists expect there will be 6-8 more increases over the next 12 months. These actions by the Fed are intended to counterbalance inflation, an approach that has proven effective in the past. However, the impact of rate hikes will surely have a slow-burn effect – over the course of months and likely even years, especially since current inflation is heavily influenced by the pandemic.

Typically, there is advance notice of pending action by the Fed, followed by a phase-in period by financial institutions. This means that while accessing capital or arranging for equipment financing will incur more interest cost over time, rate increases will be incremental. While short-term access to capital may not be a problem for many providers, others rely upon borrowing and direct financing options. In any case, a buyer seeking to use financing will find historically low rates in the near term, but with each succeeding Fed announcement, borrowing costs will continue to increase. Thus, there will be real cost savings for those who act sooner rather than later. Furthermore, financing equipment today has the double benefit of locking in current pricing AND current interest rates.

What You Can Do

  1. Finance Equipment. A financial solutions provider can access capital funds on a customer’s behalf that will lock in today’s pricing and thus shield the end user from ongoing increases – even in the midst of lengthy supply chain delays. The shield comes in the form of fixed-rate payments. Assets acquired through financing are thus based on today’s prices and paid later with inflated dollars over a multi-year lease term. Most healthcare institutions in the United States have, in some way or another, utilized financing at some point to deal with things like capital budget shortfalls or to preserve cashflow.
  2. Rent Equipment. Rental of critical care equipment has always been an important tool for hospitals in peak-need situations. During the pandemic, rental became a crucial means of quickly meeting equipment needs as patient census levels surged and then persisted for many months. As patient levels have dropped at healthcare facilities, demand for rental services has diminished as well. With providers now evaluating long-term equipment needs with shrinking capital budgets, equipment rental can address needs in the short-term and the long-term. Equipment rental remains an affordable avenue to acquire equipment.

Rental and financing solutions address two vastly different ends of the equipment acquisition spectrum in healthcare. As providers learn to utilize these tools more effectively in a complimentary manner, they can become invaluable solutions for navigating through challenging and even unpredictable economic times.

The Bottom Line

Rising inflation and interest rates are certain to erode margins and even feasibility for new equipment acquisition in the near and long term. A solid hedging strategy should include partnering with companies that provide rental and financing options to reduce the sting of inflationary pressure and help healthcare providers become stronger than ever.

Rising Equipment Costs & What Healthcare Providers Can Do About It (beckershospitalreview.com)

The Great Resignation is becoming a “great midlife crisis”

Older, more tenured people are increasingly quitting their jobs.By Rani Molla@ranimolla  Apr 30, 2022, 8:00am EDT

With prices soaring and analysts predicting a recession on the horizon, it might not seem like the best time to quit your job. But that’s not keeping American workers, especially older, more tenured ones, from doing so.

Higher-paid workers are increasingly quitting their jobs, as the Great Resignation — also known as the Great Reshuffle — enters its second year. Earlier in the pandemic, the trend was led by younger, less-tenured workers in low-paying industries like retail, food service, and health care. Now, the main growth in quit rates is coming from older, more tenured workers in higher-paid industries like finance, tech, and other knowledge worker fields, according to data from two separate human resources and analytics companies. These workers say they are searching for less tangible benefits like meaning and flexibility.

That changing composition of who is quitting paints an increasingly complicated picture of the state of work in America and suggests that while quit rates have decreased slightly from their highs last year, the phenomenon is not going away just yet.

“The Great Resignation is almost like a train, where it’s built all this momentum and it’s hard to slow down, but certain workers are getting off the train and new workers are coming on,” said Luke Pardue, an economist at Gusto, which provides payroll, benefits, and human resource management software to small- and medium-sized businesses.

Rates of quits are always highest among younger, less senior workers — those who tend to be less invested in their jobs and whose lives are less stable. This was true during the early stages of the pandemic when these workers quit their jobs amid heightened demand to eke out better wages and conditions elsewhere (though those gains are unlikely to be permanent). But those quit rates have been declining. Data from Gusto, which typically works with companies that have around 25 employees, shows that the average tenure of people who quit has grown in every age group and in nearly every industry. In other words, older people who’ve worked at a job longer are also quitting.

A similar change is happening at bigger companies, according to data from people analytics provider Visier.https://datawrapper.dwcdn.net/ceS03/1/https://datawrapper.dwcdn.net/yDfl6/1/

Between the first quarter of 2021 and 2022, the greatest growth in resignations was among people aged 40 to 60 and those with a tenure of more than 10 years, a Visier dataset from companies with over 1,000 employees shows. Older and more tenured people are especially likely to be quitting in knowledge worker industries like finance and tech.

Their reasons are myriad.

“Don’t look for one thing that’s driving the Great Resignation,” Ian Cook, Visier’s vice president of people analytics, told Recode. “It’s actually made up from a combination of different patterns and will continue to change as the labor market changes and as the economic recovery changes.”

Among the more financially stable set, quits are being driven by everything from a desire to continue working remotely to a greater search for meaning to simply having the means to do so.

Columbia Business School professor Adam Galinsky calls this iteration of the Great Resignation the “great midlife crisis.”

“At the midpoint of life, we become aware of our own mortality, and it allows us to reflect on what really matters to us,” said Galinsky. The pandemic has amplified that effect. “A global pandemic obviously makes people reflect on their own mortality in terms of being afraid of dying themselves or having a loved one or family and colleagues pass away.”

Importantly, the people who quit to hold out for the jobs they want or forgo work entirely are usually the ones with the financial means to do so.

Galinsky, who is currently on sabbatical in Hawaii, says he’s seen it among his peers and among other high-earning knowledge workers now working from his island getaway. He mentioned a Bloomberg employee who quit after the finance publication called workers back to the office and who now works on a pasta truck.

Such workers, either due to savings or a spouse’s income, have the freedom to look for other work, including gig work or starting their own business. A Gusto survey of new businesses shows that they’ve shifted from e-commerce startups earlier in the pandemic to more professional services, like, say, an accountant starting her own firm rather than working for someone else.

Many of these workers, especially those who are older and more stable in their careers, now have the perspective to consider what they really want out of their lives and work.

After more than two years of successfully working from home, many knowledge workers are loath to come back to the office, and some are jumping ship if they feel they have to do so. That makes sense. Data from Slack’s ongoing survey of 10,000 knowledge workers just found that with a third of them now back in the office five days a week, their work-related stress and anxiety has reached its highest level since the survey began in 2020.

Growth in knowledge worker quits also might just simply be a case of people copying one another.

“Workers who have this experience, that switched a job, that became more flexible, talk about it and how they had a great experience, and that leads their neighbor or their friend to do the same,” Pardue said.

They’re also quitting because there are a lot of jobs out there for them. The number of business and professional services job openings is at a record high, according to Bureau of Labor Statistics data. According to job site Indeed, the number of high-paid job postings has not cooled as much as postings for low-paid jobs (postings for both remain above pre-pandemic levels).

So while the future might look grim, the present looks just fine for these workers, who are confident in the current tight job market. As Galinsky put it, “People believe less in global warming on days it snows.”

Older workers in higher-paid industries are joining the Great Resignation – Vox

Inflation, supply chain shortages making it harder, more expensive to obtain needed medical equipment

Exam tables are backlogged for four to five months

By Daniella Genovese FOXBusiness

The ongoing supply chain disruptions have made it difficult for medical officials to get their hands on much-needed equipment from wheelchairs, crutches to canes and even exam tables. 

The war in Ukraine is only exacerbating those supply chain issues – which persisted over the past two years – because Russia is a major producer of nickel, chrome and steel, Cindy Juhas, chief strategy officer of CME Corp. told FOX Business. 

As a result, it’s taking “two to three times longer to get things,” she said. And when they come in, the cost for these products have surged due in part because of an increase in freight and raw material costs. 

CME is the largest equipment-focused national medical distributor in the U.S., offering more than 2 million products from more than 2,000 manufacturers.

stretchers

Stretchers assembled by CME.  (CME Corp.   )

“So far, in 2022, we’re already seeing annual price increases that are up to quadruple or even five times higher than usual,” Juhas said. The company reviewed 339 pricing contracts from a total of 167 top medical vendors.

Juhas said the manufacturer for one of CME’s most popular wheelchairs added a 20% surcharge to cover the cost of raw materials and freight for the product in the last four months alone. 

The costs for crutches have also gone up about 20%, although they have been hard to even get, she said. 

Meanwhile, exam tables, have gone up between 20 to 30% and are also backlogged about four to five months, according to Juhas. 

To underscore this issue, the American Hospital Association reported that between, the fall of 2020 and early 2022, the cost for energy, resins, cotton and most metals “surged in excess of 30%.” 

“These all are critical elements in the manufacturing of medical supplies and devices used every day in hospitals,” the AHA said. 

As a result, hospitals “turned to local suppliers and non-traditional suppliers, often paying significantly higher rates than they did prior to the pandemic.” 

GET FOX BUSINESS ON THE GO BY CLICKING HERE  

Some healthcare centers around the country even resorted to asking for donations for equipment.

Joey Kamerath, senior medical director for rehabilitation services at Intermountain Healthcare, said the department’s supply chain has run “completely dry.”

To help, Intermountain alongside University of Utah Health, Steward Health and the Utah Hospital Association created a program called LeanOnUtah in order to collect metal crutches, walkers, canes, and non-motorized wheelchairs.

medical equipment supply chain issues

CME obtains truckloads and truckloads of medical equipment at its warehouses around the country. (CME)

Likewise, Charleston Area Medical Center in West Virginia announced last fall that the pandemic and supply disruptions created a “nationwide shortage of adult crutches” and its vendors have been unable to fill orders. 

The medical center asked its Facebook followers “for anyone who may have crutches at home and not in use to consider donating them to patients,” adding that these donations “will help those who may need crutches when they are discharged from the hospital after an injury or surgery.”

Juhas projected that these issues – an increase in costs and shortage of supplies – will persist at least until the end of the year and maybe even into the first quarter of 2023. 

Inflation, supply chain shortages making it harder, more expensive to obtain needed medical equipment | Fox Business

Hospital expenses per inpatient day across 50 states

Ayla Ellison (Twitter)

Below are the adjusted expenses per inpatient day in 2020, organized by hospital ownership type, in all 50 states, according to the latest statistics from Kaiser State Health Facts

These figures, which are based on information from the 2020 American Hospital Association Annual Survey, include all operating and nonoperating expenses for registered U.S. community hospitals, defined as public, nonfederal, short-term general and other hospitals. The figures are an estimate of the expenses incurred in a day of inpatient care and have been adjusted higher to reflect an estimate of the volume of outpatient services, according to the Kaiser Family Foundation.

United States 

  • State/local government hospitals: $2,606
  • Nonprofit hospitals: $3,032
  • For-profit hospitals: $2,300 

Alabama

  • State/local government hospitals: $1,749
  • Nonprofit hospitals: $1,913
  • For-profit hospitals: $1,719 

Alaska

  • State/local government hospitals: $1,658 
  • Nonprofit hospitals: $2,156 
  • For-profit hospitals: $3,342 

Arizona

  • State/local government hospitals: $2,611
  • Nonprofit hospitals: $3,253 
  • For-profit hospitals: $2,804

Arkansas

  • State/local government hospitals: $2,713
  • Nonprofit hospitals: $1,852 
  • For-profit hospitals: $1,783 

California

  • State/local government hospitals: $3,886
  • Nonprofit hospitals: $4,464
  • For-profit hospitals: $2,708 

Colorado 

  • State/local government hospitals: $2,713 
  • Nonprofit hospitals: $3,633
  • For-profit hospitals: $3,153

Connecticut

  • State/local government hospitals: $5,557 
  • Nonprofit hospitals: $3,251 
  • For-profit hospitals: $2,287 

Delaware

  • State/local government hospitals: N/A
  • Nonprofit hospitals: $3,391 
  • For-profit hospitals: $1,122 

Florida

  • State/local government hospitals: $2,435
  • Nonprofit hospitals: $2,866 
  • For-profit hospitals: $2,111 

Georgia

  • State/local government hospitals: $779
  • Nonprofit hospitals: $2,420 
  • For-profit hospitals: $2,161 

Hawaii

  • State/local government hospitals: $1,916 
  • Nonprofit hospitals: $3,150 
  • For-profit hospitals: N/A

Idaho 

  • State/local government hospitals: $1,926 
  • Nonprofit hospitals: $3,169 
  • For-profit hospitals: $2,795 

Illinois

  • State/local government hospitals: $3,188 
  • Nonprofit hospitals: $2,939 
  • For-profit hospitals: $2,474 

Indiana

  • State/local government hospitals: $1,669 
  • Nonprofit hospitals: $3,243 
  • For-profit hospitals: $2,726 

Iowa

  • State/local government hospitals: $1,789 
  • Nonprofit hospitals: $1,791 
  • For-profit hospitals: $1,376 

Kansas

  • State/local government hospitals: $2,019 
  • Nonprofit hospitals: $2,263 
  • For-profit hospitals: $2,401 

Kentucky

  • State/local government hospitals: $2,440 
  • Nonprofit hospitals: $2,283 
  • For-profit hospitals: $2,286 

Louisiana

  • State/local government hospitals: $1,999 
  • Nonprofit hospitals: $2,496 
  • For-profit hospitals: $,2292

Maine

  • State/local government hospitals: $1,573 
  • Nonprofit hospitals: $2,967 
  • For-profit hospitals: $1,194 

Maryland

  • State/local government hospitals: N/A
  • Nonprofit hospitals: $3,344 
  • For-profit hospitals: $1,559 

Massachusetts

  • State/local government hospitals: $2,598 
  • Nonprofit hospitals: $3,651 
  • For-profit hospitals: $2,251 

Michigan

  • State/local government hospitals: $1,136 
  • Nonprofit hospitals: $2,787 
  • For-profit hospitals: $2,382 

Minnesota

  • State/local government hospitals: $2,065 
  • Nonprofit hospitals: $2,648 
  • For-profit hospitals: N/A

Mississippi

  • State/local government hospitals: $1,157 
  • Nonprofit hospitals: $1,424
  • For-profit hospitals: $1,728 

Missouri

  • State/local government hospitals: $2,147 
  • Nonprofit hospitals: $2,847 
  • For-profit hospitals: $2,097 

Montana

  • State/local government hospitals: $671 
  • Nonprofit hospitals: $2,060 
  • For-profit hospitals: $3,235 

Nebraska

  • State/local government hospitals: $1,510 
  • Nonprofit hospitals: $2,600 
  • For-profit hospitals: $3,141 

Nevada

  • State/local government hospitals: $3,179 
  • Nonprofit hospitals: $2,537 
  • For-profit hospitals: $2,186 

New Hampshire 

  • State/local government hospitals: N/A
  • Nonprofit hospitals: $3,238 
  • For-profit hospitals: $3,321

New Jersey 

  • State/local government hospitals: $1,922 
  • Nonprofit hospitals: $3,409 
  • For-profit hospitals: $2,250 

New Mexico

  • State/local government hospitals: $3,466 
  • Nonprofit hospitals: $3,259 
  • For-profit hospitals: $2,731

New York

  • State/local government hospitals: $3,800 
  • Nonprofit hospitals: $3,652 
  • For-profit hospitals: N/A

North Carolina

  • State/local government hospitals: $2,389 
  • Nonprofit hospitals: $2,603 
  • For-profit hospitals: $2,395 

North Dakota

  • State/local government hospitals: N/A 
  • Nonprofit hospitals: $1,788 
  • For-profit hospitals: $5,579 

Ohio

  • State/local government hospitals: $3,530 
  • Nonprofit hospitals: $3,245 
  • For-profit hospitals: $2,291 

Oklahoma

  • State/local government hospitals: $1,830 
  • Nonprofit hospitals: $2,243 
  • For-profit hospitals: $2,444

Oregon

  • State/local government hospitals: $4,855 
  • Nonprofit hospitals: $3,848 
  • For-profit hospitals: $3,290 

Pennsylvania 

  • State/local government hospitals: $926 
  • Nonprofit hospitals: $2,859 
  • For-profit hospitals: $2,210 

Rhode Island

  • State/local government hospitals: N/A
  • Nonprofit hospitals: $3,019 
  • For-profit hospitals: N/A

South Carolina

  • State/local government hospitals: $2,545 
  • Nonprofit hospitals: $2,352 
  • For-profit hospitals: $1,944 

South Dakota

  • State/local government hospitals: $812 
  • Nonprofit hospitals: $1,593 
  • For-profit hospitals: $4,788 

Tennessee

  • State/local government hospitals: $1,895 
  • Nonprofit hospitals: $2,671 
  • For-profit hospitals: $1,941 

Texas

  • State/local government hospitals: $3,639 
  • Nonprofit hospitals: $3,113 
  • For-profit hospitals: $2,274 

Utah

  • State/local government hospitals: $3,055 
  • Nonprofit hospitals: $3,609 
  • For-profit hospitals: $3,097 

Vermont

  • State/local government hospitals: N/A
  • Nonprofit hospitals: $3,114 
  • For-profit hospitals: N/A

Washington

  • State/local government hospitals: $4,294 
  • Nonprofit hospitals: $3,803 
  • For-profit hospitals: $4,707 

West Virginia

  • State/local government hospitals: $1,412 
  • Nonprofit hospitals: $2,289 
  • For-profit hospitals: $1,171 

Wisconsin

  • State/local government hospitals: $4,060 
  • Nonprofit hospitals: $2,725 
  • For-profit hospitals: $2,913

Wyoming

  • State/local government hospitals: $1,170 
  • Nonprofit hospitals: $3,546
  • For-profit hospitals: $2,612 

Hospital expenses per inpatient day across 50 states (beckershospitalreview.com)

Hospital drug spending jumps 8.4% in 2021

Katie Adams – Thursday, April 7th, 2022 

The country’s total drug spending increased by 7.7 percent in 2021, growing to $576.9 billion, according to a study released April 6 by the American Society of Health-System Pharmacists. 

Hospitals accounted for $39.6 billion of that spending, marking 8.4 percent growth from 2020. Clinics accounted for $105 billion, a 7.7 percent increase

Gilead’s COVID-19 therapeutic remdesivir made up nearly 10 percent of what hospitals spent on drugs in 2021. Hospitals’ remdesivir spending outpaced the next three drugs combined, according to the study.

“The drug-spending whiplash that clinics and hospitals experienced in the first year of the pandemic did not end with 2021,” Eric Tichy, PharmD, division chair of supply chain management at Rochester, Minn.-based Mayo Clinic and lead study author, said in a statement. “Uncertainty remains around how long the federal government will continue to pay for COVID treatments, and around inflation, which is moving through most economic sectors.”

Becker’s Hospital Review